Decreased β-catenin levels in the retinas of the diabetic and OIR KO mice. by Kelu Kevin Zhou (637715)

Down-regulation of Gli decreased ovarian cancer cell migration and invasion. by Qi Chen (144168)

Bufalin downregulates SRC–3 and decreases cell viability in TNBC cells. by Xianzhou Song (803006)

“…<p>(A) Western blot shows that bufalin (100 nM) downregulates SRC–3 protein levels in TNBC cells. …”

Oligospermia and decreased fertility in <i>Chtf18</i>-null mice. by Karen M. Berkowitz (123502)

Loss of Fmrp leads to decreased neuronal differentiation but increased astrocyte differentiation. by Yuping Luo (147790)

“…(E,F), Luciferase reporter assay showing that differentiating <i>Fmr1</i> KO aNPCs had decreased <i>NeuroD1</i> (E; n = 4, p<0.01), but increased GFAP (F, n = 3, p<0.05) promoter activities compared with WT aNPCs. …”

Increased miR200c decreases FAP-1 expression. by Sabarinathan Ramachandran (444500)

FGF8b decreased GnRH mRNA in GT1-7 cells. by Natasha N. Mott (341221)

Loss of C9orf72 decreases mTOR activation. by Janet Ugolino (3359054)

“…C9orf72-/- MEF cells show a decrease in p-S6K1 when compared with wild-type cells. …”

IL-1Ra expressed by MSCs decreased Th17 differentiation. by Kijun Lee (4888660)

<i>Rbfox3</i> deletion decreased the thickness of the IPL in the retina. by Yi-Sian Lin (3193446)

Reduction of Tks5 expression in tumor cells is associated with decreased angiogenesis. by Barbara Blouw (715467)

JNK and ERK phosphorylation is decreased by inhibitors of Rho kinase and actin polymerization. by Hui-Ju Hsu (242886)

DICER protein expression is significantly decreased in the absence of MOV10 and FMRP. by Monica C. Lannom (11772729)

SUI-sEVs decreased the migration ability of primary cultured fibroblasts. by Xiaoyan Sun (28501)

Heart specific RNase Z variants show a mild decrease in longevity and locomotor response. by Ekaterina Migunova (15909887)

FSS rescues homocysteine-caused the decrease of NO production in cultured HUVECs after the application of A23187. by Cathy W. C. Bi (108697)

Effects of siRNA TMPRSS2-ERG on ERG protein expression and cell viability. by Giorgia Urbinati (554921)

“…MTT cell viability assay:</b> VCaP cells were transfected with siRNA TMPRSS2-ERG III (1, 2), TMPRSS2-ERG IV (1) and siRNA Control at 50 nM concentration and incubated for 72h. Bars represent mean ± SD of 2 independent experiments containing 8 replicates for each condition. …”

The distributions of the end-simulation adolescence-limited proportion when (a) <i>k</i> is increased or decreased by 50%, (b) <i>c</i> is increased or decreased by 50%, (c) <i>γ</i> is increased or decreased by 50%, and (d) Δ<i>e</i> is increased or decreased by 50%, compared against the benchmark distribution <i>F</i>(<b>p</b>₀) for the parameters shown in Table 1. by Jia Ning Leaw (752775)

Low concentrations of siRNA TMPRSS2-ERG III and IV impair TMPRSS2-ERG oncogene and oncoprotein levels but not cell viability. by Giorgia Urbinati (554921)

“…<p>VCaP cells were transfected for 72h from 2.5 nM to 50 nM with siRNA TMPRSS2-ERG III, siRNA TMPRSS2-ERG IV or siRNA Control. …”

<i>T. cruzi</i> PCM abrogates MAP kinase activation and decreased MAP kinase signaling results in inhibition of ctgf/ccn2 expression. by G. Adam Mott (198973)